Innovent Biologics Eulerpool Novinky

Innovent Biologics Novinky o akciách

Innovent Biologics sledujú mnohí novinári a investori po celom svete. Najaktuálnejšie správy Innovent Biologics zhromažďujeme práve tu.

• 17. januára ·

  Yahoo
  CDE grants BTD to Innovent’s IBI343 for pancreatic cancer
• 17. januára ·

  Yahoo
  Innovent Presents at the 43rd Annual J.P. Morgan Healthcare Conference
• 8. januára ·

  Yahoo
  High Growth Tech Stocks Innovent Biologics And 2 Other Promising Picks
• 3. januára ·

  Yahoo
  Innovent Announces Second New Drug Application of DOVBLERON ® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) was Approved by China's National Medical Products Administration
• 2. januára ·

  Yahoo
  Innovent and Roche link on lung cancer therapy development
• 2. januára ·

  Yahoo
  Innovent Enters into Exclusive Global License Agreement with Roche for Novel DLL3 Antibody Drug Conjugate
• 27. decembra ·

  Yahoo
  Mankind Pharma and Innovent partner for Sintilimab commercialisation in India
• 20. decembra ·

  Yahoo
  Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration
• 10. decembra ·

  Yahoo
  Exploring Three High Growth Tech Stocks For Potential Expansion
• 9. decembra ·

  Yahoo
  Innovent Presents Updated Data From Innovative Anti-CLDN18.2 ADC (IBI343) Phase 1 Study in Patients with Advanced Pancreatic Cancer at the ESMO Asia Congress 2024